More tools:Markets·Screener·Research Chat

BeOne Medicines Ltd. American Depositary Shares (ONC) Financial Statements

BeOne Medicines Ltd. American Depositary Shares
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00B6WF7V2
XNAS · usd
306.56▲ 2.60 (0.86%)
As of 2026-07-14
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)$5.7B
Net Income (TTM)$513.0M
EBITDA
Diluted EPS (TTM)
EBITDA Margin14.6%
Net Debt
Trading Information
Previous Close303.96
Day's Range302.55 – 308.20
52-Week Range249.12 – 385.22
Volume419.3K
Avg Volume310.4K
Share Statistics
Shares Outstanding1.4B
Employees12.0K
ExchangeXNAS
Listed2016-02-03

Key questions about BeOne Medicines Ltd. American Depositary Shares (ONC)

What is BeOne Medicines Ltd. American Depositary Shares's Market Cap?
BeOne Medicines Ltd. American Depositary Shares's Market Cap is $443.1B, based on as-reported figures from SEC (XBRL) filings.
What is BeOne Medicines Ltd. American Depositary Shares's Enterprise Value?
BeOne Medicines Ltd. American Depositary Shares's Enterprise Value is $31.0B, based on as-reported figures from SEC (XBRL) filings.
What is BeOne Medicines Ltd. American Depositary Shares's Trailing P/E?
BeOne Medicines Ltd. American Depositary Shares's Trailing P/E is 863.6×, based on as-reported figures from SEC (XBRL) filings.
What is BeOne Medicines Ltd. American Depositary Shares's Price / Sales?
BeOne Medicines Ltd. American Depositary Shares's Price / Sales is 77.2×, based on as-reported figures from SEC (XBRL) filings.
What is BeOne Medicines Ltd. American Depositary Shares's EV / Revenue?
BeOne Medicines Ltd. American Depositary Shares's EV / Revenue is 5.4×, based on as-reported figures from SEC (XBRL) filings.
What is BeOne Medicines Ltd. American Depositary Shares's EV / EBITDA?
BeOne Medicines Ltd. American Depositary Shares's EV / EBITDA is 37.1×, based on as-reported figures from SEC (XBRL) filings.
What is BeOne Medicines Ltd. American Depositary Shares's Revenue (TTM)?
BeOne Medicines Ltd. American Depositary Shares's Revenue (TTM) is $5.7B, based on as-reported figures from SEC (XBRL) filings.
What is BeOne Medicines Ltd. American Depositary Shares's Net Income (TTM)?
BeOne Medicines Ltd. American Depositary Shares's Net Income (TTM) is $513.0M, based on as-reported figures from SEC (XBRL) filings.
What is BeOne Medicines Ltd. American Depositary Shares's EBITDA?
BeOne Medicines Ltd. American Depositary Shares's EBITDA is $836.0M, based on as-reported figures from SEC (XBRL) filings.
What is BeOne Medicines Ltd. American Depositary Shares's Diluted EPS (TTM)?
BeOne Medicines Ltd. American Depositary Shares's Diluted EPS (TTM) is 0.35, based on as-reported figures from SEC (XBRL) filings.
Loading Income Statement…
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022
Product revenue, net
Other revenue——
Total revenues
YoY growth+35.5%+32.8%+41.0%+41.6%
Cost of sales - product
Gross profit
% of revenue89.0%90.5%86.1%87.5%
Research and development
Selling, general and administrative
Total operating expenses
% of revenue72.4%78.1%74.5%80.8%
Income from operations
% of revenue16.5%12.4%11.5%6.7%
Interest income———
Interest expense———
Other income, net
Income before income taxes
Income tax expense
Net income
% of revenue15.0%4.4%8.8%7.2%
Basic
Diluted
Weighted-average shares outstanding—basic
Weighted-average shares outstanding—diluted
Weighted-average ADSs outstanding—basic
Weighted-average ADSs outstanding—diluted